MARKET

AKSY

AKSY

Aksys
EXMKT
0.0000
NaN%
Closed 09:30 03/14 EDT
OPEN
--
PREV CLOSE
0.0000
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0000
52 WEEK LOW
0.0000
MARKET CAP
32.45
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AKSY last week (0303-0307)?
Weekly Report · 6d ago
Weekly Report: what happened at AKSY last week (0224-0228)?
Weekly Report · 03/03 11:28
Weekly Report: what happened at AKSY last week (0217-0221)?
Weekly Report · 02/24 11:28
Weekly Report: what happened at AKSY last week (0210-0214)?
Weekly Report · 02/17 11:25
Weekly Report: what happened at AKSY last week (0203-0207)?
Weekly Report · 02/10 11:19
Weekly Report: what happened at AKSY last week (0127-0131)?
Weekly Report · 02/03 11:23
Weekly Report: what happened at AKSY last week (0120-0124)?
Weekly Report · 01/27 11:27
Weekly Report: what happened at AKSY last week (0113-0117)?
Weekly Report · 01/20 11:18
More
About AKSY
Aksys, Ltd. manufactures an automated personal hemodialysis system for patients suffering from end stage renal disease(chronic kidney failure). Patients are able to perform hemodialysis in a self- care setting on a daily basis. The Company's product is a computerized product that has an integrated automatic disinfection system. The patient can also be monitored by a treatment clinic via a real-time, on-line monitoring system. The system can evaluate prior to each treatment the amount of toxins being removed to ensure that the prescribed dose of hemodialysis is achieved.

Webull offers Aksys Ltd stock information, including EXMKT: AKSY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKSY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKSY stock methods without spending real money on the virtual paper trading platform.